Phathom Pharmaceuticals, Inc. (PHAT)
12.78
+0.20
(+1.59%)
USD |
NASDAQ |
Feb 09, 16:00
12.95
+0.17
(+1.33%)
Pre-Market: 09:11
Phathom Pharmaceuticals EPS Diluted (Quarterly) : -0.4084 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Vanda Pharmaceuticals, Inc. | -0.3822 |
| Immuneering Corp. | -0.3772 |
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Alnylam Pharmaceuticals, Inc. | 1.840 |
| Savara, Inc. | -0.1366 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -29.97M |
| Revenue (Quarterly) | 49.50M |
| Total Expenses (Quarterly) | 79.48M |
| Enterprise Value | 1.445B |
| Gross Profit Margin (Quarterly) | 87.50% |
| Profit Margin (Quarterly) | -60.55% |
| Earnings Yield | -29.83% |
| Normalized Earnings Yield | -29.83 |